- Tytuł:
- Simvastatin activates the PPARγ-dependent pathway to prevent left ventricular hypertrophy associated with inhibition of RhoA signaling.
- Autorzy:
- Źródło:
- Texas Heart Institute journal [Tex Heart Inst J] 2013; Vol. 40 (2), pp. 140-7.
- Typ publikacji:
- Journal Article
- MeSH Terms:
-
Heart Failure/*drug therapy
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*pharmacology
Hypertrophy, Left Ventricular/*prevention & control
Myocardium/*enzymology
PPAR gamma/*drug effectsSignal Transduction /*drug effects
Simvastatin/*pharmacology
rhoA GTP-Binding Protein/*metabolism
Animals ; Disease Models, Animal ; Fibrosis ; Heart Failure/diagnostic imaging ; Heart Failure/enzymology ; Heart Failure/physiopathology ; Hypertrophy, Left Ventricular/diagnostic imaging ; Hypertrophy, Left Ventricular/enzymology ; Hypertrophy, Left Ventricular/physiopathology ; Myocardium/pathology ; PPAR gamma/genetics ; PPAR gamma/metabolism ; RNA, Messenger/metabolism ; Rabbits ; Transcription Factor RelA/metabolism ; Ultrasonography
Czasopismo naukowe